217 related articles for article (PubMed ID: 37269817)
1. PRMT1 methylates METTL14 to modulate its oncogenic function.
Wang J; Wang Z; Inuzuka H; Wei W; Liu J
Neoplasia; 2023 Aug; 42():100912. PubMed ID: 37269817
[TBL] [Abstract][Full Text] [Related]
2. Arginine methylation of METTL14 promotes RNA N
Liu X; Wang H; Zhao X; Luo Q; Wang Q; Tan K; Wang Z; Jiang J; Cui J; Du E; Xia L; Du W; Chen D; Xia L; Xiao S
Nat Commun; 2021 Jun; 12(1):3780. PubMed ID: 34145242
[TBL] [Abstract][Full Text] [Related]
3. m
Wang Z; Pan Z; Adhikari S; Harada BT; Shen L; Yuan W; Abeywardana T; Al-Hadid Q; Stark JM; He C; Lin L; Yang Y
EMBO J; 2021 Mar; 40(5):e106309. PubMed ID: 33459381
[TBL] [Abstract][Full Text] [Related]
4. METTL3 regulates m6A in endometrioid epithelial ovarian cancer independently of METTl14 and WTAP.
Ma Z; Li Q; Liu P; Dong W; Zuo Y
Cell Biol Int; 2020 Dec; 44(12):2524-2531. PubMed ID: 32869897
[TBL] [Abstract][Full Text] [Related]
5. Mettl14-mediated m6A modification is essential for visual function and retinal photoreceptor survival.
Yang Y; Shuai P; Li X; Sun K; Jiang X; Liu W; Le W; Jiang H; Liu Y; Zhu X
BMC Biol; 2022 Jun; 20(1):140. PubMed ID: 35698136
[TBL] [Abstract][Full Text] [Related]
6. PRMT1 methylation of WTAP promotes multiple myeloma tumorigenesis by activating oxidative phosphorylation via m6A modification of NDUFS6.
Jia Y; Yu X; Liu R; Shi L; Jin H; Yang D; Zhang X; Shen Y; Feng Y; Zhang P; Yang Y; Zhang L; Zhang P; Li Z; He A; Kong G
Cell Death Dis; 2023 Aug; 14(8):512. PubMed ID: 37558663
[TBL] [Abstract][Full Text] [Related]
7. Substrate profiling of PRMT1 reveals amino acid sequences that extend beyond the "RGG" paradigm.
Wooderchak WL; Zang T; Zhou ZS; Acuña M; Tahara SM; Hevel JM
Biochemistry; 2008 Sep; 47(36):9456-66. PubMed ID: 18700728
[TBL] [Abstract][Full Text] [Related]
8. Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase.
Ping XL; Sun BF; Wang L; Xiao W; Yang X; Wang WJ; Adhikari S; Shi Y; Lv Y; Chen YS; Zhao X; Li A; Yang Y; Dahal U; Lou XM; Liu X; Huang J; Yuan WP; Zhu XF; Cheng T; Zhao YL; Wang X; Rendtlew Danielsen JM; Liu F; Yang YG
Cell Res; 2014 Feb; 24(2):177-89. PubMed ID: 24407421
[TBL] [Abstract][Full Text] [Related]
9. Arginine methylation of BCL-2 antagonist of cell death (BAD) counteracts its phosphorylation and inactivation by Akt.
Sakamaki J; Daitoku H; Ueno K; Hagiwara A; Yamagata K; Fukamizu A
Proc Natl Acad Sci U S A; 2011 Apr; 108(15):6085-90. PubMed ID: 21444773
[TBL] [Abstract][Full Text] [Related]
10. Reduced N6-Methyladenosine Mediated by METTL3 Acetylation Promotes MTF1 Expression and Hepatocellular Carcinoma Cell Growth.
Yang Y; Qian Cai Q; Sheng Fu L; Wei Dong Y; Fan F; Zhong Wu X
Chem Biodivers; 2022 Nov; 19(11):e202200333. PubMed ID: 36149370
[TBL] [Abstract][Full Text] [Related]
11. RNA secondary structure dependence in METTL3-METTL14 mRNA methylation is modulated by the N-terminal domain of METTL3.
Meiser N; Mench N; Hengesbach M
Biol Chem; 2020 Nov; 402(1):89-98. PubMed ID: 33544495
[No Abstract] [Full Text] [Related]
12. METTL14 is a chromatin regulator independent of its RNA N6-methyladenosine methyltransferase activity.
Dou X; Huang L; Xiao Y; Liu C; Li Y; Zhang X; Yu L; Zhao R; Yang L; Chen C; Yu X; Gao B; Qi M; Gao Y; Shen B; Sun S; He C; Liu J
Protein Cell; 2023 Sep; 14(9):683-697. PubMed ID: 37030005
[TBL] [Abstract][Full Text] [Related]
13. NSUN2-Mediated m5C Methylation and METTL3/METTL14-Mediated m6A Methylation Cooperatively Enhance p21 Translation.
Li Q; Li X; Tang H; Jiang B; Dou Y; Gorospe M; Wang W
J Cell Biochem; 2017 Sep; 118(9):2587-2598. PubMed ID: 28247949
[TBL] [Abstract][Full Text] [Related]
14. Arginine methylation-dependent regulation of ASK1 signaling by PRMT1.
Cho JH; Lee MK; Yoon KW; Lee J; Cho SG; Choi EJ
Cell Death Differ; 2012 May; 19(5):859-70. PubMed ID: 22095282
[TBL] [Abstract][Full Text] [Related]
15. Protein arginine methylation of SERBP1 by protein arginine methyltransferase 1 affects cytoplasmic/nuclear distribution.
Lee YJ; Hsieh WY; Chen LY; Li C
J Cell Biochem; 2012 Aug; 113(8):2721-8. PubMed ID: 22442049
[TBL] [Abstract][Full Text] [Related]
16. Analysis of METTL3 and METTL14 in hepatocellular carcinoma.
Liu X; Qin J; Gao T; Li C; Chen X; Zeng K; Xu M; He B; Pan B; Xu X; Pan Y; Sun H; Xu T; Wang S
Aging (Albany NY); 2020 Nov; 12(21):21638-21659. PubMed ID: 33159022
[TBL] [Abstract][Full Text] [Related]
17. METTL3 Intensifies the Progress of Oral Squamous Cell Carcinoma via Modulating the m6A Amount of PRMT5 and PD-L1.
Ai Y; Liu S; Luo H; Wu S; Wei H; Tang Z; Li X; Lv X; Zou C
J Immunol Res; 2021; 2021():6149558. PubMed ID: 34476262
[TBL] [Abstract][Full Text] [Related]
18. Deep Protein Methylation Profiling by Combined Chemical and Immunoaffinity Approaches Reveals Novel PRMT1 Targets.
Hartel NG; Chew B; Qin J; Xu J; Graham NA
Mol Cell Proteomics; 2019 Nov; 18(11):2149-2164. PubMed ID: 31451547
[TBL] [Abstract][Full Text] [Related]
19. Alphaherpesvirus US3 protein-mediated inhibition of the m6A mRNA methyltransferase complex.
Jansens RJJ; Verhamme R; Mirza AH; Olarerin-George A; Van Waesberghe C; Jaffrey SR; Favoreel HW
Cell Rep; 2022 Jul; 40(3):111107. PubMed ID: 35858564
[TBL] [Abstract][Full Text] [Related]
20. Interactions, localization, and phosphorylation of the m
Schöller E; Weichmann F; Treiber T; Ringle S; Treiber N; Flatley A; Feederle R; Bruckmann A; Meister G
RNA; 2018 Apr; 24(4):499-512. PubMed ID: 29348140
[No Abstract] [Full Text] [Related]
[Next] [New Search]
